Abstract:Phosphoinositide 3-kinases (PI3Ks) are lipid kinases essential for growth and metabolism. Their aberrant activation is associated with many types of cancers. Here we used single-particle cryoelectron microscopy (cryo-EM) to determine three distinct conformations of full-length PI3K alpha (p110 alpha-p85 alpha): the unliganded heterodimer PI3K alpha, PI3K alpha bound to the p110 alpha-specific inhibitor BYL-719, and PI3K alpha exposed to an activating phosphopeptide. The cryo-EM structures of unbound and of BYL-719-bound PI3K alpha are in general accord with published crystal structures. Local deviations are presented and discussed. BYL-719 stabilizes the structure of PI3K alpha, but three regions of low-resolution extra density remain and are provisionally assigned to the cSH2, BH, and SH3 domains of p85. One of the extra density regions is in contact with the kinase domain blocking access to the catalytic site. This conformational change indicates that the effects of BYL-719 on PI3K alpha activity extend beyond competition with adenosine triphosphate (ATP). In unliganded PI3K alpha, the DFG motif occurs in the "in" and "out" positions. In BYL-719-bound PI3K alpha, only the DFG-in position, corresponding to the active conformation of the kinase, was observed. The phosphopeptide-bound structure of PI3K alpha is composed of a stable core resolved at 3.8 angstrom. It contains all p110 alpha domains except the adaptor-binding domain (ABD). The p85 alpha domains, linked to the core through the ABD, are no longer resolved, implying that the phosphopeptide activates PI3K alpha by fully releasing the niSH2 domain from binding to p110 alpha. The structures presented here show the basal form of the full-length PI3K alpha dimer and document conformational changes related to the activated and inhibited states.

Crystal Structure of the N-Terminal Sh3 Domain of Mouse Beta Pix, P21-Activated Kinase-Interacting Exchange Factor

Crystallization and Preliminary X-ray Crystallographic Analysis of the Human CKIP-1 Pleckstrin Homology Domain.

Cryo-EM structures of PI3K reveal conformational changes during inhibition and activation

Cloning, purification, crystallization and preliminary X-ray diffraction analysis of mouse PACSIN 3 protein.

Cloning, Purification, Crystallization and Preliminary X-ray Crystallographic Analysis of SET/TAF-Iβ ΔN Fromhomo Sapiens

Crystal Structure of the Yeast Phox Homology (PX) Domain Protein Grd19p Complexed to Phosphatidylinositol-3-phosphate

Expression, crystallization and preliminary X-ray studies of the recombinant PTB domain of mouse dok1 protein.

Crystal Structure of Human Eif3k, the First Structure of Eif3 Subunits*

Crystal Structure of Inhibitor of Kappa B Kinase Beta

Solution Structure Of The Sh3 Domain Of Dock180

Structural basis of beta-catenin recognition by Tax-interacting protein-1.

Integrated in Silico-in Vitro Characterization, Identification and Disruption of the Intermolecular Interaction Between SH3 Domain-Containing Protein Kinases and Human Pituitary Tumor-Transforming Gene 1.

Crystal Structure of the PX Domain of SNX27

Crystal structures of p120RasGAP N-terminal SH2 domain in its apo form and in complex with a p190RhoGAP phosphotyrosine peptide

Crystal Structure of the SH3 Domain of ASAP1 in Complex with the Proline Rich Motif (PRM) of MICAL1 Reveals a Unique SH3/PRM Interaction Mode

NpgRJ_Nn_1822 32..39

Structural Basis of β-Catenin Recognition by Tax-interacting Protein-1

Protein Preparation, Crystallization and Preliminary X-Ray Analysis of the C-Terminal Domain of Human Rsk1 Serine/Threonine Protein Kinase

Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3.

Crystal Structure of Human ASB9-2 and Substrate-Recognition of CKB

Crystal Structure of the PX Domain of SNX 27 CRYSTAL STRUCTURE OF PX DOMAIN OF SNX 27